(Q37454955)

20 August 2017

1 reference

title

Effect of pregnancy on the pharmacokinetics of antihypertensive drugs (English)

1 reference

20 August 2017

1 reference

Gail D Anderson

1

1 reference

PubMed ID

19385709

20 August 2017

Darcy B Carr

series ordinal

2

1 reference

20 August 2017

1 January 2009

1 reference

Clinical Pharmacokinetics

20 August 2017

1 reference

20 August 2017

48

1 reference

20 August 2017

3

1 reference

20 August 2017

159-168

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200948030-00002

20 August 2017

0 references

cites work

Atenolol in the treatment of pregnancy‐induced hypertension

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003088-200948030-00002

Nifedipine concentration in maternal and umbilical cord blood after nifedipine gastrointestinal therapeutic system for tocolysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003088-200948030-00002

An in vitro technique for the rapid determination of drug entry into breast milk

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003088-200948030-00002

Atenolol and metoprolol. A comparison of their excretion into human breast milk

21 January 2018

1 reference

12 December 2020

Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants

1 reference

12 December 2020

Nifedipine serum levels in pregnant women undergoing tocolysis with nifedipine

1 reference

12 December 2020

Glomerular filtration during and after pregnancy.

1 reference

12 December 2020

The effect of hydralazine on steady-state plasma concentrations of metoprolol in pregnant hypertensive women

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic evaluation of atenolol during and after pregnancy

1 reference

12 December 2020

Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials

1 reference

12 December 2020

Measurements of maternal protein binding of bupivacaine throughout pregnancy.

1 reference

12 December 2020

Treating hypertension in women of child-bearing age and during pregnancy

1 reference

12 December 2020

Prediction of drug distribution into human milk from physicochemical characteristics.

1 reference

12 December 2020

Excretion of diltiazem in human milk

1 reference

12 December 2020

Nifedipine pharmacokinetics and pharmacodynamics during the immediate postpartum period in patients with preeclampsia

1 reference

12 December 2020

Pregnancy-induced increase in metoprolol metabolism

1 reference

12 December 2020

Clonidine hydrochloride--a safe and effective antihypertensive agent in pregnancy

1 reference

12 December 2020

Clonidine kinetics in man‐evidence for dose dependency and changed pharmacokinetics during chronic therapy

1 reference

12 December 2020

Oral nifedipine pharmacokinetics in pregnancy-induced hypertension

1 reference

12 December 2020

Pharmacokinetics of furosemide in gestosis of pregnancy

1 reference

12 December 2020

Transfer of labetalol into amniotic fluid and breast milk in lactating women.

1 reference

12 December 2020

Toxic effects of atenolol consumed during breast feeding

1 reference

12 December 2020

Use of labetalol in the treatment of severe hypertension during pregnancy

1 reference

12 December 2020

Drugs in human milk. Clinical pharmacokinetic considerations

1 reference

12 December 2020

Pharmacokinetics of methyldopa. Plasma levels following single intravenous, oral and multiple oral dosage in normotensive and hypertensive subjects.

1 reference

12 December 2020

Management of mild chronic hypertension during pregnancy: a review

1 reference

12 December 2020

Outpatient use of cardiovascular drugs during pregnancy

1 reference

12 December 2020

Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination

1 reference

12 December 2020

The excretion of enalapril and enalaprilat in human breast milk

1 reference

12 December 2020

A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy

1 reference

12 December 2020

Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.

1 reference

12 December 2020

Maternal hemodynamic changes associated with furosemide treatment

1 reference

12 December 2020

Clinical significance of pharmacokinetic models of hepatic elimination

1 reference

12 December 2020

Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy

1 reference

12 December 2020

Atenolol in essential hypertension during pregnancy

1 reference

12 December 2020

Comparative pharmacokinetics of oral versus sublingual clonidine.

1 reference

12 December 2020

Prazosin in normal subjects: plasma levels, blood pressure and heart rate

1 reference

12 December 2020

Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.

1 reference

12 December 2020

Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension

1 reference

12 December 2020

Renal hemodynamics and tubular function normal human pregnancy

1 reference

12 December 2020

Assessment of the hepatic arterial and portal venous blood flows during pregnancy with Doppler ultrasonography.

1 reference

12 December 2020

Oral beta-blockers for mild to moderate hypertension during pregnancy

1 reference

12 December 2020

Plasma concentration of ?-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester

1 reference

12 December 2020

Pharmacokinetics of clonidine during pregnancy and nursing

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of hypertensive complications in pregnancy

1 reference

12 December 2020

Nifedipine is excreted in human milk

1 reference

12 December 2020

Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).

1 reference

12 December 2020

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

1 reference

12 December 2020

Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation

1 reference

12 December 2020

Captopril in human blood and breast milk

1 reference

12 December 2020

Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age

1 reference

12 December 2020

Serum protein binding of drugs during and after pregnancy in humans.

1 reference

12 December 2020

Nifedipine pharmacokinetics during preterm labor tocolysis

1 reference

12 December 2020

Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension

1 reference

12 December 2020

Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance

1 reference

12 December 2020

Changes in plasma protein binding have little clinical relevance

1 reference

12 December 2020

Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine of mothers and offspring

1 reference

12 December 2020

Caffeine as a metabolic probe: validation of its use for acetylator phenotyping

1 reference

12 December 2020

Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach

1 reference

12 December 2020

Studying drugs in human milk: time to unify the approach.

1 reference

12 December 2020

Increased oral clearance of metoprolol in pregnancy

1 reference

12 December 2020

Labetalol pharmacokinetics in pregnancy-induced hypertension

1 reference

12 December 2020

Disposition of a new rate-controlled formulation of prazosin in the treatment of hypertension during pregnancy: transplacental passage of prazosin

1 reference

12 December 2020

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.

1 reference

12 December 2020

Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth

1 reference

12 December 2020

Prediction of milk/plasma concentration ratio of drugs

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum

1 reference

12 December 2020

Clonidine and breast-feeding

1 reference

12 December 2020

Labetalol disposition and concentration-effect relationships during pregnancy

1 reference

12 December 2020

10.2165/00003088-200948030-00002

Identifiers

DOI

1 reference

PubMed ID

19385709

Dimensions Publication ID

20 August 2017

0 references

1 reference

PubMed ID

19385709